Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1.

Weekes D, Kashima TG, Zandueta C, Perurena N, Thomas DP, Sunters A, Vuillier C, Bozec A, El-Emir E, Miletich I, Patiño-Garcia A, Lecanda F, Grigoriadis AE.

Oncogene. 2016 Jun 2;35(22):2948. doi: 10.1038/onc.2015.420. No abstract available.

PMID:
27251742
2.

Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1.

Weekes D, Kashima TG, Zandueta C, Perurena N, Thomas DP, Sunters A, Vuillier C, Bozec A, El-Emir E, Miletich I, Patiño-Garcia A, Lecanda F, Grigoriadis AE.

Oncogene. 2016 Jun 2;35(22):2852-61. doi: 10.1038/onc.2015.344. Epub 2015 Sep 21. Erratum in: Oncogene. 2016 Jun 2;35(22):2948.

3.

Homologous and heterologous desensitization of guanylyl cyclase-B signaling in GH3 somatolactotropes.

Thompson IR, Mirczuk SM, Smith L, Lessey AJ, Simbi B, Sunters A, Baxter GF, Lipscomb VJ, McGonnell IM, Wheeler-Jones CP, Mukherjee A, Roberson MS, McArdle CA, Fowkes RC.

Cell Tissue Res. 2014 Feb;355(2):425-36. doi: 10.1007/s00441-013-1763-y. Epub 2013 Dec 20.

4.

Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β.

Galea GL, Meakin LB, Sugiyama T, Zebda N, Sunters A, Taipaleenmaki H, Stein GS, van Wijnen AJ, Lanyon LE, Price JS.

J Biol Chem. 2013 Mar 29;288(13):9035-48. doi: 10.1074/jbc.M112.405456. Epub 2013 Jan 29.

5.

A specific role for phosphoinositide 3-kinase and AKT in osteoblasts?

McGonnell IM, Grigoriadis AE, Lam EW, Price JS, Sunters A.

Front Endocrinol (Lausanne). 2012 Jul 20;3:88. doi: 10.3389/fendo.2012.00088. eCollection 2012.

6.

Lrp5 is not required for the proliferative response of osteoblasts to strain but regulates proliferation and apoptosis in a cell autonomous manner.

Javaheri B, Sunters A, Zaman G, Suswillo RF, Saxon LK, Lanyon LE, Price JS.

PLoS One. 2012;7(5):e35726. doi: 10.1371/journal.pone.0035726. Epub 2012 May 2.

7.
8.

Loading-related regulation of transcription factor EGR2/Krox-20 in bone cells is ERK1/2 protein-mediated and prostaglandin, Wnt signaling pathway-, and insulin-like growth factor-I axis-dependent.

Zaman G, Sunters A, Galea GL, Javaheri B, Saxon LK, Moustafa A, Armstrong VJ, Price JS, Lanyon LE.

J Biol Chem. 2012 Feb 3;287(6):3946-62. doi: 10.1074/jbc.M111.252742. Epub 2011 Nov 2.

9.

Sost down-regulation by mechanical strain in human osteoblastic cells involves PGE2 signaling via EP4.

Galea GL, Sunters A, Meakin LB, Zaman G, Sugiyama T, Lanyon LE, Price JS.

FEBS Lett. 2011 Aug 4;585(15):2450-4. doi: 10.1016/j.febslet.2011.06.019. Epub 2011 Jun 28.

10.

Role of endocrine and paracrine factors in the adaptation of bone to mechanical loading.

Price JS, Sugiyama T, Galea GL, Meakin LB, Sunters A, Lanyon LE.

Curr Osteoporos Rep. 2011 Jun;9(2):76-82. doi: 10.1007/s11914-011-0050-7. Review.

PMID:
21384138
11.

Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer.

Chen J, Gomes AR, Monteiro LJ, Wong SY, Wu LH, Ng TT, Karadedou CT, Millour J, Ip YC, Cheung YN, Sunters A, Chan KY, Lam EW, Khoo US.

PLoS One. 2010 Aug 20;5(8):e12293. doi: 10.1371/journal.pone.0012293.

13.

Loading-related regulation of gene expression in bone in the contexts of estrogen deficiency, lack of estrogen receptor alpha and disuse.

Zaman G, Saxon LK, Sunters A, Hilton H, Underhill P, Williams D, Price JS, Lanyon LE.

Bone. 2010 Mar;46(3):628-42. doi: 10.1016/j.bone.2009.10.021. Epub 2009 Oct 24.

14.

The mouse fibula as a suitable bone for the study of functional adaptation to mechanical loading.

Moustafa A, Sugiyama T, Saxon LK, Zaman G, Sunters A, Armstrong VJ, Javaheri B, Lanyon LE, Price JS.

Bone. 2009 May;44(5):930-5. doi: 10.1016/j.bone.2008.12.026. Epub 2009 Jan 14.

15.

Mechanical loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on trabecular and cortical bone in mice.

Sugiyama T, Saxon LK, Zaman G, Moustafa A, Sunters A, Price JS, Lanyon LE.

Bone. 2008 Aug;43(2):238-48. doi: 10.1016/j.bone.2008.04.012. Epub 2008 May 1.

PMID:
18539556
16.

The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells.

Krol J, Francis RE, Albergaria A, Sunters A, Polychronis A, Coombes RC, Lam EW.

Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3169-79.

17.

Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha.

Armstrong VJ, Muzylak M, Sunters A, Zaman G, Saxon LK, Price JS, Lanyon LE.

J Biol Chem. 2007 Jul 13;282(28):20715-27. Epub 2007 May 8.

18.

Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt.

Sunters A, Madureira PA, Pomeranz KM, Aubert M, Brosens JJ, Cook SJ, Burgering BM, Coombes RC, Lam EW.

Cancer Res. 2006 Jan 1;66(1):212-20.

19.

ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line.

Varshochi R, Halim F, Sunters A, Alao JP, Madureira PA, Hart SM, Ali S, Vigushin DM, Coombes RC, Lam EW.

J Biol Chem. 2005 Feb 4;280(5):3185-96. Epub 2004 Nov 19.

20.

Aberrant p53 alters DNA damage checkpoints in response to cisplatin: downregulation of CDK expression and activity.

Wrighton KH, Prêle CM, Sunters A, Yeudall WA.

Int J Cancer. 2004 Dec 10;112(5):760-70.

21.

The expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblasts.

Palmieri C, Saji S, Sakaguchi H, Cheng G, Sunters A, O'Hare MJ, Warner M, Gustafsson JA, Coombes RC, Lam EW.

J Mol Endocrinol. 2004 Aug;33(1):35-50.

PMID:
15291741
22.

The expression of ER beta cx in human breast cancer and the relationship to endocrine therapy and survival.

Palmieri C, Lam EW, Mansi J, MacDonald C, Shousha S, Madden P, Omoto Y, Sunters A, Warner M, Gustafsson JA, Coombes RC.

Clin Cancer Res. 2004 Apr 1;10(7):2421-8.

23.

Accelerated cell cycle progression in osteoblasts overexpressing the c-fos proto-oncogene: induction of cyclin A and enhanced CDK2 activity.

Sunters A, Thomas DP, Yeudall WA, Grigoriadis AE.

J Biol Chem. 2004 Mar 12;279(11):9882-91. Epub 2003 Dec 29.

24.

Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.

Zhao C, Lam EW, Sunters A, Enmark E, De Bella MT, Coombes RC, Gustafsson JA, Dahlman-Wright K.

Oncogene. 2003 Oct 23;22(48):7600-6.

PMID:
14576822
25.

FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines.

Sunters A, Fernández de Mattos S, Stahl M, Brosens JJ, Zoumpoulidou G, Saunders CA, Coffer PJ, Medema RH, Coombes RC, Lam EW.

J Biol Chem. 2003 Dec 12;278(50):49795-805. Epub 2003 Oct 3.

26.

Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1beta-induced paracrine growth factor for human breast cells.

Palmieri C, Roberts-Clark D, Assadi-Sabet A, Coope RC, O'Hare M, Sunters A, Hanby A, Slade MJ, Gomm JJ, Lam EW, Coombes RC.

J Endocrinol. 2003 Apr;177(1):65-81.

PMID:
12697038
27.

Inhibition of chondrocyte differentiation in vitro by constitutive and inducible overexpression of the c-fos proto-oncogene.

Thomas DP, Sunters A, Gentry A, Grigoriadis AE.

J Cell Sci. 2000 Feb;113 ( Pt 3):439-50.

28.
29.

Control of cell cycle gene expression in bone development and during c-Fos-induced osteosarcoma formation.

Sunters A, McCluskey J, Grigoriadis AE.

Dev Genet. 1998;22(4):386-97.

PMID:
9664690
30.

DNA repair capacity and cisplatin sensitivity of human testis tumour cells.

Köberle B, Grimaldi KA, Sunters A, Hartley JA, Kelland LR, Masters JR.

Int J Cancer. 1997 Mar 4;70(5):551-5.

31.

The use of alpha-DNA as an internal standard in the detection and quantitation of DNA damage in specific genes using Southern blotting.

Sunters A, Grimaldi KA, Souhami RL, Hartley JA.

Nucleic Acids Res. 1996 Jun 15;24(12):2456-7. No abstract available.

32.
33.

Cytotoxicity and activation of CB1954 in a human tumour cell line.

Sunters A, Baer J, Bagshawe KD.

Biochem Pharmacol. 1991 May 1;41(9):1293-8.

PMID:
2018561

Supplemental Content

Loading ...
Support Center